Bone marrow mesenchymal stem cells are abnormal in multiple myeloma

Cluster analysis and display of genome-wide expression patterns

Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 12,617 · see citing works

A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

Attal, M., Harousseau, J.-L., Stoppa, A.-M., Sotto, J.-J., Fuzibet, J.-G., Rossi, J.-F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607113350204 · Cited by 2,548 · see citing works

The microenvironment of the tumour–host interface

Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,322 · see citing works

Stromal fibroblasts in cancer initiation and progression

Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,291 · see citing works

A PROSPECTIVE, RANDOMIZED TRIAL OF AUTOLOGOUS BONE MARROW TRANSPLANTATION AND CHEMOTHERAPY IN MULTIPLE MYELOMA

Ttal, M. I. A., Ean, J., Dünne, A. A., Toppa, A. S., Ossi, R. G., Hilippe, P., Asassus, C., Acon, T. H. F., Orbert, N., Ayen, C. A. P., et al. (2013) · Cited by 2,161 · see citing works

An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction

Gregory, C. A., Gunn, W., Peister, A., & Prockop, D. J. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.02.002 · Cited by 1,568 · see citing works

The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma

Tian, E., Zhan, F., Walker, R. C., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,499 · see citing works

Molecular characterization of the tumor microenvironment in breast cancer

Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299 · see citing works

Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

Attal, M., Harousseau, J.-L., Facon, T., Guilhot, F., Doyen, C., Fuzibet, J.-G., Monconduit, M., Hulin, C., Caillot, D., Bouabdallah, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032290 · Cited by 984 · see citing works

Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma

(2004) · New England Journal of Medicine · doi:10.1056/nejm200406173502526 · Cited by 817 · see citing works

Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications

Gupta, D., Treon, S. P., Shima, Y., Hideshima, T., Podar, K., Tai, Y.-T., Lin, B. K., Lentzsch, S., Davies, F. E., Chauhan, D., et al. (2001) · Leukemia · doi:10.1038/sj.leu.2402295 · Cited by 554 · see citing works

Distinct epigenetic changes in the stromal cells of breast cancers

Hu, M., Yao, J., Cai, L., Bachman, K., van den Brûle, F., Velculescu, V. E., & Polyák, K. (2005) · Nature Genetics · doi:10.1038/ng1596 · Cited by 520 · see citing works

Interleukin-6 in human multiple myeloma

Klein, B., Zhang, X., Lu, Z., & Bataille, R. (1995) · Blood · doi:10.1182/blood.v85.4.863.bloodjournal854863 · Cited by 519 · see citing works

Requirement for the lp A1 lysophosphatidic acid receptor gene in normal suckling behavior

Contos, J. J. A., Fukushima, N., Weiner, J. A., Kaushal, D., & Chun, J. J. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13384 · Cited by 479 · see citing works

Analysis of high density expression microarrays with signed-rank call algorithms

Liu, W.-M., Mei, R., Di, X., Ryder, T. B., Hubbell, E. A., Dee, S., Webster, T. A., Harrington, C. A., Ho, M.-H., Baid, J., et al. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.12.1593 · Cited by 426 · see citing works

Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion

Uchiyama, H., Barut, B., Mohrbacher, A., Chauhan, D., & Anderson, K. C. (1993) · Blood · doi:10.1182/blood.v82.12.3712.3712 · Cited by 419 · see citing works

The stroma as a crucial target in rat mammary gland carcinogenesis

Maffini, M. V., Soto, A. M., Calabro, J. M., Ucci, A. A., & Sonnenschein, C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01000 · Cited by 417 · see citing works

Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2

Oshima, T., Abe, M., Asano, J., Hara, T., Kitazoe, K.-I., Sekimoto, E., Tanaka, Y., Shibata, H., Hashimoto, T., Ozaki, S., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4940 · Cited by 344 · see citing works

Angiopoietin-Like 4 Is a Proangiogenic Factor Produced during Ischemia and in Conventional Renal Cell Carcinoma

Jan, S. L., Amy, C., Cazes, A., Monnot, C., Lamandé, N., Favier, J., Philippe, J., Sibony, M., Gasc, J., Corvol, P. L., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64285-x · Cited by 342 · see citing works

Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis

Starnes, T., Broxmeyer, H. E., Robertson, M. J., & Hromas, R. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.642 · Cited by 331 · see citing works

The Wnt Signaling Inhibitor Dickkopf-1 Is Required for Reentry into the Cell Cycle of Human Adult Stem Cells from Bone Marrow

Gregory, C. A., Singh, H., Perry, A. S., & Prockop, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300373200 · Cited by 283 · see citing works

Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma

Zhang, X., Gaillard, J., Robillard, N., Lu, Z., Gu, Z., Jourdan, M., Boiron, J.-M., Bataille, R., & Klein, B. (1994) · Blood · doi:10.1182/blood.v83.12.3654.3654 · Cited by 277 · see citing works

Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers

Koopmann, J., Buckhaults, P., Brown, D. A., ZAHURAK, M. L., Sato, N., Fukushima, N., Sokoll, L. J., Chan, D. W., Yeo, C. J., Hruban, R. H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0165 · Cited by 274 · see citing works

MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma.

Brown, D. A., Ward, R. L., Buckhaults, P., Liu, T., Romans, K. E., Hawkins, N. J., Bauskin, A. R., Kinzler, K. W., Vogelstein, B., & Breit, S. N. (2003) · PubMed · Cited by 265 · see citing works

A Crosstalk Between Myeloma Cells and Marrow Stromal Cells Stimulates Production of DKK1 and Interleukin-6: A Potential Role in the Development of Lytic Bone Disease and Tumor Progression in Multiple Myeloma

Gunn, W., Conley, A., Deininger, L., Olson, S. D., Prockop, D. J., & Gregory, C. A. (2005) · Stem Cells · doi:10.1634/stemcells.2005-0220 · Cited by 260 · see citing works

'Role of bone marrow stromal cells in the growth of human multiple myeloma

Caligaris‐Cappio, F., Bergui, L., Gregoretti, M. G., Gaïdano, G., Gaboli, M. P., M., S., Zallone, A., & Marchisio, P. (1991) · Blood · doi:10.1182/blood.v77.12.2688.bloodjournal77122688 · Cited by 234 · see citing works

Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation

Tarte, K., Zhan, F., Vos, J. D., Klein, B., & Shaughnessy, J. D. (2003) · Blood · doi:10.1182/blood-2002-10-3161 · Cited by 215 · see citing works

Cell–cell contact between marrow stromal cells and myeloma cells via VCAM-1 and α4β1-integrin enhances production of osteoclast-stimulating activity

Michigami, T., Shimizu, N., Williams, P. J., Niewolna, M., Dallas, S. L., Mundy, G. R., & Yoneda, T. (2000) · Blood · doi:10.1182/blood.v96.5.1953.h8001953_1953_1960 · Cited by 213 · see citing works

Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients

Zannettino, A. C. W., Farrugia, A. N., Kortesidis, A., Manavis, J., To, L. B., Martin, S. K., Diamond, P., Tamamura, H., Lapidot, T., Fujii, N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1687 · Cited by 205 · see citing works

The Transforming Growth Factor-β Superfamily Cytokine Macrophage Inhibitory Cytokine-1 Is Present in High Concentrations in the Serum of Pregnant Women1

Moore, A. G., Brown, D. A., Fairlie, W. D., Bauskin, A. R., Brown, P. K., Munier, M. L. C., Russell, P. K., Salamonsen, L. A., Wallace, E. M., & Breit, S. N. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7007 · Cited by 181 · see citing works

Expression of a novel member of the TGF-β superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues

Bottner, M. B., Suter‐Crazzolara, C., Schober, A., & Unsicker, K. (1999) · Cell and Tissue Research · doi:10.1007/s004410051337 · Cited by 180 · see citing works

Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells.

Liu, T., Bauskin, A. R., Zaunders, J. J., Brown, D. A., Pankhurst, S., Russell, P. J., Breit, S. N., & Panhurst, S. (2003) · PubMed · Cited by 174 · see citing works

Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth

Bajou, K., Maillard, C., Jost, M., Lijnen, R. H., Gils, A., Declerck, P. J., Carmeliet, P., Foidart, J.-M., & Noël, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207859 · Cited by 164 · see citing works

The Propeptide Mediates Formation of Stromal Stores of PROMIC-1: Role in Determining Prostate Cancer Outcome

Bauskin, A. R., Brown, D. A., Junankar, S. R., Rasiah, K., Eggleton, S. A., Hunter, M. I., Liu, T., Smith, D., Kuffner, T., Pankhurst, G. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3827 · Cited by 154 · see citing works

Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway

Ferlin, M., Noraz, N., Hertogh, C., Brochier, J., Taylor, N. N., & Klein, B. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02364.x · Cited by 153 · see citing works

WISP-1 Is an Osteoblastic Regulator Expressed During Skeletal Development and Fracture Repair

French, D. M., Kaul, R. J., D’Souza, A. L., Crowley, C. W., Bao, M., Frantz, G. D., Filvaroff, E. H., & Desnoyers, L. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63348-2 · Cited by 152 · see citing works

Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene ( Npr3 )

Jaubert, J., Jaubert, F., Martín, N., Washburn, L. L., Lee, B. K., Eicher, E. M., & Guénet, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10278 · Cited by 146 · see citing works

Growth Differentiation Factor-15 Prevents Low Potassium-induced Cell Death of Cerebellar Granule Neurons by Differential Regulation of Akt and ERK Pathways

Subramaniam, S., Strelau, J., & Unsicker, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210037200 · Cited by 134 · see citing works

Common Cancer Biomarkers

Bassil, C. F., Zhao, Y., Zavaglia, K. M., Jin, P., Panelli, M. C., Voiculescu, S. E., Mandruzzato, S., Lee, H. M., Seliger, B., Freedman, R. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3433 · Cited by 127 · see citing works

Hyaluronic Acid Induces Survival and Proliferation of Human Myeloma Cells through an Interleukin-6-mediated Pathway Involving the Phosphorylation of Retinoblastoma Protein

Vincent, T., Jourdan, M., Sy, M., Klein, B., & Mechti, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003965200 · Cited by 122 · see citing works

Attraction of human monocytes by the neuropeptide secretoneurin

Reinisch, N., Kirchmair, R., Kähler, C. M., Hogue‐Angeletti, R., Fischer‐Colbrie, R., Winkler, H. J. S., & Wiedermann, C. J. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81676-q · Cited by 119 · see citing works

The Phospholipids Sphingosine-1-Phosphate and Lysophosphatidic Acid Prevent Apoptosis in Osteoblastic Cells via a Signaling Pathway Involving Gi Proteins and Phosphatidylinositol-3 Kinase

Grey, A. B., Chen, Q., Callon, K. E., Xu, X., Reid, I. R., & Cornish, J. (2002) · Endocrinology · doi:10.1210/en.2002-220347 · Cited by 114 · see citing works

Impaired osteoblastogenesis in myeloma bone disease: role of upregulated apoptosis by cytokines and malignant plasma cells

Silvestris, F., Cafforio, P., Calvani, N., & Dammacco, F. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05084.x · Cited by 105 · see citing works

Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells

Mahtouk, K., Hose, D., Reme, T. X., Vos, J. D., Jourdan, M., Moreaux, J., Fiol, G., Raab, M. S., Jourdan, É., Grau, V., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208536 · Cited by 105 · see citing works

Advances in Biology and Therapy of Multiple Myeloma

Barillé‐Nion, S., Barlogie, B., Bataille, R., Bergsagel, P. L., Epstein, J., Fenton, R. G., Jacobson, J. L., Kuehl, W. M., Shaughnessy, J. D., & Tricot, G. J. K. (2003) · Hematology · doi:10.1182/asheducation-2003.1.248 · Cited by 91 · see citing works

Interleukin‐1 in multiple myeloma: producer cells and their role in the control of IL‐6 production

Costes, V., Portier, M., Lu, Z.-Y., Rossi, J., Bataille, R., & Klein, B. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01101.x · Cited by 88 · see citing works

Interleukin-6 dependence of advanced malignant plasma cell dyscrasias

Zhang, X., Bataille, R., Widjenes, J., & Klein, B. (1992) · Cancer · doi:10.1002/1097-0142(19920315)69:6 · Cited by 83 · see citing works

Comparison of Interleukin-1β Expression by In Situ Hybridization in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Lacy, M. Q., Donovan, K. A., Heimbach, J. K., Ahmann, G. J., & Lust, J. A. (1999) · Blood · doi:10.1182/blood.v93.1.300 · Cited by 81 · see citing works

Novel therapies for multiple myeloma

Hayashi, T., Hideshima, T., & Anderson, K. C. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.03929.x · Cited by 76 · see citing works

Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease

Silvestris, F., Cafforio, P., Tucci, M., Grinello, D., & Dammacco, F. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04374.x · Cited by 72 · see citing works

Characterization of hyaluronan synthase expression and hyaluronan synthesis in bone marrow mesenchymal progenitor cells: predominant expression of HAS1 mRNA and up-regulated hyaluronan synthesis in bone marrow cells derived from multiple myeloma patients

Calabro, A. R., Oken, M. M., Hascall, V., & Masellis-Smith, A. (2002) · Blood · doi:10.1182/blood-2002-01-0030 · Cited by 69 · see citing works

Microarray‐based understanding of normal and malignant plasma cells

Vos, J. D., Hose, D., Reme, T. X., Tarte, K., Moreaux, J., Mahtouk, K., Jourdan, M., Goldschmidt, H., Rossi, J., Cremer, F. W., et al. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00362.x · Cited by 64 · see citing works

Lysophosphatidic Acid Is an Osteoblast Mitogen Whose Proliferative Actions Involve Gi Proteins and Protein Kinase C, But Not P42/44 Mitogen-Activated Protein Kinases

Grey, A. B., Banovic, T., Naot, D., Hill, B. L., Callon, K. E., Reid, I. R., & Cornish, J. (2001) · Endocrinology · doi:10.1210/endo.142.3.8011 · Cited by 61 · see citing works

Lack of IL‐1 secretion from human myeloma cells highly purified by immunomagnetic separation

Børset, M., Helseth, E., Naume, B., & Waage, A. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb03331.x · Cited by 58 · see citing works

Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies

Wijdenes, J., Clément, C., Klein, B., Morel-Fourrier, B., Vita, N., Ferrara, P., & Peters, A. (1991) · Molecular Immunology · doi:10.1016/0161-5890(91)90004-4 · Cited by 42 · see citing works

Host Plasminogen Activator Inhibitor-1 Promotes Human Skin Carcinoma Progression in a Stage-Dependent Manner

Maillard, C., Jost, M., Rømer, M. U., Brünner, N., Houard, X., Lejeune, A., Munaut, C., Bajou, K., Mélen, L., Danø, K., et al. (2005) · Neoplasia · doi:10.1593/neo.04406 · Cited by 41 · see citing works

In vitro growth and osteoblastic differentiation of human bone marrow stromal cells supported by autologous plasma

Schecroun, N., & Delloye, C. (2004) · Bone · doi:10.1016/j.bone.2004.03.029 · Cited by 38 · see citing works

Characterization of bone marrow stromal cells from multiple myeloma

Gregoretti, M. G., Gottardi, D., Ghia, P., Bergui, L., Merico, F., Marchisio, P. C., & Caligaris‐Cappio, F. (1994) · Leukemia Research · doi:10.1016/0145-2126(94)90067-1 · Cited by 35 · see citing works

Myeloma bone disease

Berenson, J. R. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2005.03.001 · Cited by 28 · see citing works

Angiogenic Switch in Multiple Myeloma

Giuliani, N., Colla, S., & Rizzoli, V. (2004) · Hematology · doi:10.1080/10245330400018524 · Cited by 24 · see citing works

Human bone marrow stroma-dependent myeloma sister cell lines MOLP-6 and MOLP-7 derived from a patient with multiple myeloma.

Harashima, A., Matsuo, Y., Nishizaki, C., Kozuka, T., Fukuda, S., Sezaki, T., & Orita, K. (2000) · PubMed · Cited by 5 · see citing works

Untitled work

Berenson (2001) · doi:10.1002/1097-0142(20010401)91:7

No place like home: anatomy and function of the stem cell niche

Jones, D. L., & Wagers, A. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2319 · Cited by 794 · see citing works

Multiple myeloma

Raab, M. S., Podar, K., Breitkreutz, I., Richardson, P. G. G., & Anderson, K. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60221-x · Cited by 695 · see citing works

Targeting the bone marrow microenvironment in multiple myeloma

Kawano, Y., Moschetta, M., Manier, S., Glavey, S. V., Görgün, G., Roccaro, A. M., Anderson, K. C., & Ghobrial, I. M. (2014) · Immunological Reviews · doi:10.1111/imr.12233 · Cited by 386 · see citing works

Bone marrow microenvironment and the identification of new targets for myeloma therapy

Podar, K., Chauhan, D., & Anderson, K. C. (2008) · Leukemia · doi:10.1038/leu.2008.259 · Cited by 336 · see citing works

Treatment of Inflammatory Diseases with Mesenchymal Stem Cells

Newman, R., Yoo, D. S., LeRoux, M. A., & Danilkovitch‐Miagkova, A. (2009) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152809788462635 · Cited by 309 · see citing works

Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy

Cho, S., Anderson, K. C., & Tai, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01821 · Cited by 296 · see citing works

The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes

Tabera, S., Perez-Simon, J. A., Diez-Campelo, M., Sanchez-Abarca, L. I., Blanco, B., Lopez, A., Benito, A., Ocio, E., Sanchez-Guijo, F. M., Canizo, C., et al. (2008) · Haematologica · doi:10.3324/haematol.12857 · Cited by 283 · see citing works

Upregulation of lncRNA MEG3 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells From Multiple Myeloma Patients By Targeting BMP4 Transcription

Zhuang, W., Ge, X., Yang, S., Huang, M., Zhuang, W., Chen, P., Zhang, X., Fu, J., Qu, J., & Li, B.-Z. (2015) · Stem Cells · doi:10.1002/stem.1989 · Cited by 274 · see citing works

Regulation of stemness and stem cell niche of mesenchymal stem cells: Implications in tumorigenesis and metastasis

Zahir, N., & Tuan, R. S. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21940 · Cited by 271 · see citing works

Mesenchymal stem cells for clinical application

Sensebé, L., Krampera, M., Schrezenmeier, H., Bourin, P., & Giordano, R. (2009) · Vox Sanguinis · doi:10.1111/j.1423-0410.2009.01227.x · Cited by 258 · see citing works

Concise Review: Adult Multipotent Stromal Cells and Cancer: Risk or Benefit?

Lazennec, G., & Jørgensen, C. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1006 · Cited by 256 · see citing works

The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape

de Jong, M. M. E., Kellermayer, Z., Papazian, N., Tahri, S., Hofste op Bruinink, D., Hoogenboezem, R., Sanders, M. A., van de Woestijne, P. C., Bos, P. K., Khandanpour, C., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00931-3 · Cited by 250 · see citing works

The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression

García-Ortiz, A., Rodríguez-García, Y., Encinas, J., Maroto-Martín, E., Castellano, E., Teixidó, J., & Martínez-López, J. (2021) · Cancers · doi:10.3390/cancers13020217 · Cited by 238 · see citing works

Concise Review: Growth Differentiation Factor 15 in Pathology: A Clinical Role?

Corre, J., Hébraud, B., & Bourin, P. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0055 · Cited by 209 · see citing works

The bone marrow microenvironment – Home of the leukemic blasts

Shafat, M. S., Gnaneswaran, B., Bowles, K. M., & Rushworth, S. A. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.03.004 · Cited by 176 · see citing works

Mesenchymal stem cell secretome and regenerative therapy after cancer

Zimmerlin, L., Park, T. S., Zambidis, E. T., Donnenberg, V. S., & Donnenberg, A. D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.010 · Cited by 168 · see citing works

Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes

Guilloton, F., Caron, G., Menard, C., Pangault, C., Amé-Thomas, P., Dulong, J., Vos, J. D., Delphine Rossille, A., Henry, C., Lamy, T., et al. (2012) · Blood · doi:10.1182/blood-2011-08-370908 · Cited by 159 · see citing works

Clinical and prognostic role of annexin A2 in multiple myeloma

Seckinger, A., Meißner, T., Moreaux, J., Depeweg, D., Hillengaß, J., Hose, K., Reme, T. X., Rösen‐Wolff, A., Jauch, A. S., Schnettler, R., et al. (2012) · Blood · doi:10.1182/blood-2012-03-415588 · Cited by 157 · see citing works

Cancer immunoediting and immune dysregulation in multiple myeloma

Nakamura, K., Smyth, M. J., & Martinet, L. (2020) · Blood · doi:10.1182/blood.2020006540 · Cited by 157 · see citing works

Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors

Garayoa, M., Garcia, J. L., Santamaria, C., Garcia-Gomez, A., Blanco, J. F., Pandiella, A., Hernández, J. M., Sanchez-Guijo, F. M., del Cañizo, M.-C., Gutiérrez, N. C., et al. (2009) · Leukemia · doi:10.1038/leu.2009.65 · Cited by 148 · see citing works

Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool

Garcı́a-Castro, J., Trigueros, C., Madrenas, J., Pérez‐Simón, J. A., Rodrı́guez, R., & Menéndez, P. R. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00516.x · Cited by 148 · see citing works

Modeling sarcomagenesis using multipotent mesenchymal stem cells

Rodrı́guez, R., Rubio, R., & Menéndez, P. R. (2011) · Cell Research · doi:10.1038/cr.2011.157 · Cited by 143 · see citing works

Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity

Veirman, K. D., Wang, J., Xu, S., Leleu, X. P., Himpe, E., Maes, K., Bruyne, E. D., Valckenborgh, E. V., Vanderkerken, K., Menu, E., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.04.024 · Cited by 138 · see citing works

Human Bone Marrow Is Comprised of Adipocytes with Specific Lipid Metabolism

Attané, C., Estève, D., Chaoui, K., Iacovoni, J. S., Corre, J., Moutahir, M., Valet, P., Burlet‐Schiltz, O., Reina, N., & Muller, C. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.089 · Cited by 137 · see citing works

Multiple Myeloma Mesenchymal Stem Cells: Characterization, Origin, and Tumor-Promoting Effects

Reagan, M. R., & Ghobrial, I. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2212 · Cited by 133 · see citing works

The mesenchymal stromal cell contribution to homeostasis

Valtieri, M., & Sorrentino, A. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21521 · Cited by 130 · see citing works

Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model

Reagan, M. R., Mishima, Y., Glavey, S. V., Zhang, Y., Manier, S., Lu, Z. N., Memarzadeh, M., Zhang, Y. S., Sacco, A., Aljawai, Y. M., et al. (2014) · Blood · doi:10.1182/blood-2014-02-558007 · Cited by 127 · see citing works

Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene

Menéndez, P. R., Catalina, P., Rodrı́guez, R., Melen, G. J., Bueno, C., Arriero, M., García‐Sánchez, F., Lassaletta, Á., García‐Sánz, R., & Garcı́a-Castro, J. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20091050 · Cited by 124 · see citing works

Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow–derived mesenchymal stromal cells

Kamdje, A. H. N., Mosna, F., Bifari, F., Lisi, V., Bassi, G., Malpeli, G., Ricciardi, M., Perbellini, O., Scupoli, M. T., Pizzolo, G., et al. (2011) · Blood · doi:10.1182/blood-2010-12-326694 · Cited by 119 · see citing works

Bone marrow stromal cells from multiple myeloma patients uniquely induce bortezomib resistant NF-κB activity in myeloma cells

Markovina, S. S., Callander, N. S., O’Connor, S. L., Xu, G., Shi, Y., Leith, C. P., Kim, K., Trivedi, P., Kim, J., Hematti, P., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-176 · Cited by 113 · see citing works

Cytokine regulation networks in the cancer microenvironment

Sheu, B. (2008) · Frontiers in bioscience · doi:10.2741/3152 · Cited by 113 · see citing works

Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?

Xu, S., Veirman, K. D., Becker, A. D., Vanderkerken, K., & Riet, I. V. (2018) · Leukemia · doi:10.1038/s41375-018-0061-9 · Cited by 111 · see citing works

CD19−CD45low/−CD38high/CD138+ plasma cells enrich for human tumorigenic myeloma cells

Kim, D., Park, C. Y., Medeiros, B. C., & Weissman, I. L. (2012) · Leukemia · doi:10.1038/leu.2012.140 · Cited by 108 · see citing works

Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells

André, T., Meuleman, N., Stamatopoulos, B., De Bruyn, C., Pieters, K., Bron, D., & Lagneaux, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059756 · Cited by 107 · see citing works

Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells

Noll, J. E., Williams, S. A., Tong, C. M., Wang, H., Quach, J., Purton, L. E., Pilkington, K. R., To, L. B., Evdokiou, A., Gronthos, S., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.090977 · Cited by 106 · see citing works

Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma

Hose, D., Reme, T. X., Meißner, T., Moreaux, J., Seckinger, A., Lewis, J., Beneš, V., Benner, A., Hundemer, M., Hielscher, T., et al. (2009) · Blood · doi:10.1182/blood-2008-09-178350 · Cited by 105 · see citing works

The molecular characterization and clinical management of multiple myeloma in the post-genome era

Zhou, Y., Barlogie, B., & Shaughnessy, J. D. (2009) · Leukemia · doi:10.1038/leu.2009.160 · Cited by 104 · see citing works

Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo

Xu, S., Menu, E., Becker, A. D., Van Camp, B., Vanderkerken, K., & Van Riet, I. (2012) · Stem Cells · doi:10.1002/stem.787 · Cited by 103 · see citing works

Bioactivity and Prognostic Significance of Growth Differentiation Factor GDF15 Secreted by Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma

Corre, J., Labat, E., Espagnolle, N., Hébraud, B., Avet‐Loiseau, H., Roussel, M., Huynh, A., Gadelorge, M., Cordelier, P., Klein, B., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-0188 · Cited by 103 · see citing works

Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)

Giallongo, C., Tibullo, D., Parrinello, N. L., Cava, P. L., Rosa, M. D., Bramanti, V., Raimondo, C. D., Conticello, C., Chiarenza, A., Palumbo, G. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7969 · Cited by 100 · see citing works

Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells

Figueroa, E. F., Montesinos, J. J., Flores-Guzmán, P., Gutiérrez-Espíndola, G. R., Arana-Trejo, R. M., Castillo-Medina, S., Pérez-Cabrera, A., Hernández-Estévez, É., Arriaga‐Pizano, L., & Mayani, H. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.02.013 · Cited by 100 · see citing works

Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival

Corradi, G., Baldazzi, C., Očadlíková, D., Marconi, G., Parisi, S., Testoni, N., Finelli, C., Cavo, M., Curti, A., & Ciciarello, M. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1013-z · Cited by 97 · see citing works

The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth

Pennisi, A., Ling, W., Li, X., Khan, S., Shaughnessy, J. D., Barlogie, B., & Yaccoby, S. (2009) · Blood · doi:10.1182/blood-2009-01-201954 · Cited by 96 · see citing works

Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes

de la Guardia, R. D., López‐Millán, B., Lavoie, J. R., Bueno, C., Castaño, J., Gómez-Casares, M., Vives, S., Palomo, L., Juan, M., Delgado, J., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.04.019 · Cited by 96 · see citing works

Advances in the understanding of myeloma bone disease and tumour growth

Yaccoby, S. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08141.x · Cited by 95 · see citing works

Activation of NK cells and disruption of PD-L1/PD-1 axis: two different ways for lenalidomide to block myeloma progression

Giuliani, M., Janji, B., & Berchem, G. (2017) · Oncotarget · doi:10.18632/oncotarget.15234 · Cited by 88 · see citing works

Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment

García-Gómez, A., Rodríguez‐Ubreva, J., & Ballestar, E. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.02.013 · Cited by 86 · see citing works

Targeting signaling pathways in multiple myeloma: Pathogenesis and implication for treatments

Hu, J., & Hu, W.-X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.11.020 · Cited by 84 · see citing works

Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone

Li, X., Ling, W., Pennisi, A., Wang, Y., Khan, S., Heidaran, M. A., Pal, A., Zhang, X., He, S., Zeitlin, A., et al. (2010) · Stem Cells · doi:10.1002/stem.572 · Cited by 83 · see citing works

Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis

Pasquet, M., Golzio, M., Mery, E., Rafii, A., Benabbou, N., Mirshahi, P., Hennebelle, I., Bourin, P., Allal, B., Teissie, J., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.24886 · Cited by 82 · see citing works

Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells

Tanno, T., Lim, Y., Wang, Q., Chesi, M., Bergsagel, P. L., Matthews, G., Johnstone, R. W., Ghosh, N., Borrello, I., Huff, C. A., et al. (2013) · Blood · doi:10.1182/blood-2013-08-524025 · Cited by 82 · see citing works

Upregulation of miR-135b Is Involved in the Impaired Osteogenic Differentiation of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients

Xu, S., Santini, G., Veirman, K. D., Broek, I. V., Leleu, X. P., Becker, A. D., Camp, B. V., Vanderkerken, K., & Riet, I. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079752 · Cited by 82 · see citing works

The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment

Isidori, A., Salvestrini, V., Ciciarello, M., Loscocco, F., Visani, G., Parisi, S., Lecciso, M., Očadlíková, D., Rossi, L., Gabucci, E., et al. (2014) · Expert Review of Hematology · doi:10.1586/17474086.2014.958464 · Cited by 82 · see citing works

Mesenchymal stromal cells’ role in tumor microenvironment: involvement of signaling pathways

Kamdje, A. H. N., Kamga, P. T., Simo, R. T., Vecchio, L., Etet, P. F. S., Jm, M., Bassi, G., Lukong, K. E., Goel, R. K., Amvene, J. M., et al. (2017) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2016.0033 · Cited by 81 · see citing works

Myeloma and Bone Disease

Panaroni, C., Yee, A. J., & Raje, N. S. (2017) · Current Osteoporosis Reports · doi:10.1007/s11914-017-0397-5 · Cited by 81 · see citing works

Soluble Factors on Stage to Direct Mesenchymal Stem Cells Fate

Sobacchi, C., Palagano, E., VILLA, A. M., & Menale, C. (2017) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00032 · Cited by 80 · see citing works

Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement

Bueno, C., Montes, R., Catalina, P., Rodrı́guez, R., & Menéndez, P. R. (2010) · Leukemia · doi:10.1038/leu.2010.284 · Cited by 79 · see citing works

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis

Seckinger, A., Meißner, T., Moreaux, J., Goldschmidt, H., Fuhler, G. M., Benner, A., Hundemer, M., Reme, T. X., Shaughnessy, J. D., Barlogie, B., et al. (2009) · Oncogene · doi:10.1038/onc.2009.257 · Cited by 79 · see citing works

Bone Marrow Stromal Cells Create a Permissive Microenvironment for Myeloma Development: A New Stromal Role for Wnt Inhibitor Dkk1

Fowler, J. A., Mundy, G. R., Lwin, S. T., & Edwards, C. M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2067 · Cited by 76 · see citing works

A potential role for Dkk-1 in the pathogenesis of osteosarcoma predicts novel diagnostic and treatment strategies

Lee, N., SMOLARZ, A. J., Olson, S. D., David, O., Reiser, J., Kutner, R. H., Daw, N. C., Prockop, D. J., Horwitz, E. M., & Gregory, C. A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604069 · Cited by 77 · see citing works

Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects

García-Gómez, A., Ocio, E. M., Crusoé, E. D. Q., Santamaría, C., Hernández‐Campo, P. M., Blanco, J. F., Sanchez-Guijo, F. M., Hernández‐Iglesias, T., Briñón, J. G., Fisac-Herrero, R. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034914 · Cited by 76 · see citing works

Mesenchymal stromal cells as cancer promoters

Antoon, R., Overdevest, N., Saleh, A. H., & Keating, A. (2024) · Oncogene · doi:10.1038/s41388-024-03183-1 · Cited by 75 · see citing works

Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma

Abe, M. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0949-x · Cited by 74 · see citing works

Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model

Braham, M. V. J., Minnema, M. C., Aarts‐Riemens, T., Sebestyén, Z., Straetemans, T., Vyborova, A., Kuball, J. H. E., Öner, F. C., Robin, C., & Alblas, J. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1434465 · Cited by 73 · see citing works

Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells

Bret, C., Hose, D., Reme, T. X., Sprynski, A. C., Mahtouk, K., Schved, J., Quittet, P., Rossi, J., Goldschmidt, H., & Klein, B. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07633.x · Cited by 73 · see citing works

EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma–Induced Epigenetic Suppression of Osteoblast Differentiation

Adamik, J., Jin, S., Sun, Q., Zhang, P., Weiss, K. R., Anderson, J. L., Silbermann, R., Roodman, G. D., & Galson, D. L. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0242-t · Cited by 73 · see citing works

Growth differentiation factor 15 (GDF15) promotes osteoclast differentiation and inhibits osteoblast differentiation and high serum GDF15 levels are associated with multiple myeloma bone disease

Westhrin, M., Moen, S. H., Holien, T., Mylin, A. K., Heickendorff, L., Olsen, O. E., Sundan, A., Turesson, I., Gimsing, P., Waage, A., et al. (2015) · Haematologica · doi:10.3324/haematol.2015.124511 · Cited by 72 · see citing works

Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors

Chandran, P., Le, Y., Li, Y., Sabloff, M., Mehic, J., Rosu‐Myles, M., & Allan, D. (2015) · Leukemia Research · doi:10.1016/j.leukres.2015.01.013 · Cited by 72 · see citing works

A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications

Jakubı́ková, J., Cholujová, D., Hideshima, T., Gronesova, P., Šoltýsová, A., Harada, T., Joo, J., Kong, S., Szalat, R. E., Richardson, P. G. G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12643 · Cited by 72 · see citing works

Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration

Moreaux, J., Hose, D., Kassambara, A., Reme, T. X., Moine, P., Requirand, G., Goldschmidt, H., & Klein, B. (2010) · Blood · doi:10.1182/blood-2010-04-279760 · Cited by 71 · see citing works

GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion

Grisendi, G., Annerén, C., Cafarelli, L., Sternieri, R., Veronesi, E., Cervo, G. L., Luminari, S., Maur, M., Frassoldati, A., Palazzi, G., et al. (2010) · Cytotherapy · doi:10.3109/14653241003649510 · Cited by 71 · see citing works

Dynamic interplay between bone and multiple myeloma: Emerging roles of the osteoblast

Reagan, M. R., Liaw, L., Rosen, C. J., & Ghobrial, I. M. (2015) · Bone · doi:10.1016/j.bone.2015.02.021 · Cited by 68 · see citing works

Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?

Noll, J. E., Williams, S. A., Purton, L. E., & Zannettino, A. C. W. (2012) · Blood Cancer Journal · doi:10.1038/bcj.2012.38 · Cited by 67 · see citing works

Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo

Xu, S., De Veirman, K., Evans, H., Santini, G. C., Vande Broek, I., Leleu, X., De Becker, A., Van Camp, B., Croucher, P., Vanderkerken, K., et al. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.182 · Cited by 64 · see citing works

Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells

Zdzisińska, B., Bojarska-Junak, A. A., Dmoszyńska, A., & Kandefer‐Szerszeń, M. (2008) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-008-0022-5 · Cited by 63 · see citing works

Cell therapy with autologous mesenchymal stem cells—how the disease process impacts clinical considerations

Wang, J., Liao, L., Wang, S., & Tan, M. J. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.01.218 · Cited by 63 · see citing works

Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment

Poggi, A. D., & Giuliani, M. (2016) · Vaccines · doi:10.3390/vaccines4040041 · Cited by 62 · see citing works

Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease

Todoerti, K., Lisignoli, G., Storti, P., Agnelli, L., Novara, F., Manferdini, C., Codeluppi, K., Colla, S., Crugnola, M., Abeltino, M., et al. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.11.009 · Cited by 63 · see citing works

Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays

Mahtouk, K., Moreaux, J., Hose, D., Reme, T. X., Meißner, T., Jourdan, M., Rossi, J. F., Pals, S. T., Goldschmidt, H., & Klein, B. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-198 · Cited by 62 · see citing works

The emerging role of exosomes in multiple myeloma

Moloudizargari, M., Abdollahi, M. R., Asghari, M. H., Zimța, A., Berindan‐Neagoe, I., & Nabavi, S. M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100595 · Cited by 61 · see citing works

Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosis

Balakumaran, A., Robey, P. G., Fedarko, N. S., & Landgren, O. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.31 · Cited by 61 · see citing works

Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention

Zhou, F., Meng, S., Song, H., & Claret, F. X. (2013) · Blood Reviews · doi:10.1016/j.blre.2013.08.002 · Cited by 59 · see citing works

Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma

McNee, G. S., Eales, K. L., Wei, W., Williams, D., Barkhuizen, A., Bartlett, D. B., Essex, S., Anandram, S., Filer, A. D., Moss, P. A. H., et al. (2016) · Leukemia · doi:10.1038/leu.2016.187 · Cited by 57 · see citing works

Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease

Garcia-Gomez, A., Li, T., de la Calle-Fabregat, C., Rodríguez-Ubreva, J., Ciudad, L., Català-Moll, F., Godoy-Tena, G., Martín-Sánchez, M., San-Segundo, L., Muntión, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20715-x · Cited by 57 · see citing works

Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs)

Pacini, S. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00050 · Cited by 53 · see citing works

Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway

Xu, S., Evans, H., Buckle, C., Veirman, K. D., Hu, J., Xu, D., Menu, E., Becker, A. D., Broek, I. V., Leleu, X. P., et al. (2012) · Leukemia · doi:10.1038/leu.2012.126 · Cited by 55 · see citing works

Tumor–host cell interactions in the bone disease of myeloma

Fowler, J. A., Edwards, C. M., & Croucher, P. I. (2010) · Bone · doi:10.1016/j.bone.2010.06.029 · Cited by 55 · see citing works

Mesenchymal stem cells and their microenvironment

Ingrid, U. S. (2011) · Frontiers in bioscience · doi:10.2741/3853 · Cited by 55 · see citing works

Bone marrow inflammation in haematological malignancies

de Jong, M. M. E., Chen, L., Raaijmakers, M. H. G. P., & Cupedo, T. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01003-x · Cited by 54 · see citing works

Plasma cell disorders in HIV-infected patients: epidemiology and molecular mechanisms

Coker, W. J., Jeter, A., Schade, H. H., & Kang, Y. (2013) · Biomarker Research · doi:10.1186/2050-7771-1-8 · Cited by 54 · see citing works

Multiple myeloma: the bone marrow microenvironment and its relation to treatment

Andrews, S. W., Kabrah, S. M., May, J. E., Donaldson, C., & Morse, H. (2013) · British Journal of Biomedical Science · doi:10.1080/09674845.2013.11669945 · Cited by 53 · see citing works

Unveiling Skeletal Fragility in Patients Diagnosed With MGUS: No Longer a Condition of Undetermined Significance?

Drake, M. T. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2387 · Cited by 53 · see citing works

Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease

García-Gómez, A., Rivas, J. D. L., Ocio, E. M., Dı́az-Rodrı́guez, E., Montero, J. C., Martín, M., Blanco, J. F., Sanchez-Guijo, F. M., Pandiella, A., Miguel, J. F. S., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2058 · Cited by 53 · see citing works

The osteoblastic niche in the context of multiple myeloma

Toscani, D., Bolzoni, M., Accardi, F., Aversa, F., & Giuliani, N. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12578 · Cited by 52 · see citing works

Osteoblastogenesis and tumor growth in myeloma

Yaccoby, S. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903503438 · Cited by 52 · see citing works

Causal relationships between inflammatory factors and multiple myeloma: A bidirectional Mendelian randomization study

Wang, Q., Shi, Q., Lu, J., Wang, Z., & Hou, J. (2022) · International Journal of Cancer · doi:10.1002/ijc.34214 · Cited by 51 · see citing works

Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions

Thudi, N. K., Martin, C. K., Nadella, M. V. P., Fernández, S., Werbeck, J. L., Pinzone, J. J., & Rosol, T. J. (2008) · The Prostate · doi:10.1002/pros.20776 · Cited by 49 · see citing works

Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression

Maiso, P., Mogollón, P., Ocio, E. M., & Garayoa, M. (2021) · Cancers · doi:10.3390/cancers13112542 · Cited by 48 · see citing works

Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway

Chen, D., Tang, P., Liu, L., Wang, F., Xing, H., Sun, L., & Jiang, Z. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1442624 · Cited by 48 · see citing works

Extracellular Matrix Remodeling by Bone Marrow Fibroblast-like Cells Correlates with Disease Progression in Multiple Myeloma

Slany, A., Haudek‐Prinz, V. J., Meshcheryakova, A., Bileck, A., Lamm, W. W., Zielinski, C. C., Gerner, C., & Drach, J. W. (2013) · Journal of Proteome Research · doi:10.1021/pr400881p · Cited by 47 · see citing works

Characterization of Mesenchymal Stem Cells Abnormalities in Multiple Myeloma.

Bourin, P., Corre, J., Mahtouk, K., Gadelorge, M., Laharrague, P. F., Klein, B., Reme, T. X., & Attal, M. (2006) · Blood · doi:10.1182/blood.v108.11.511.511 · Cited by 2 · see citing works

Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma

Arnulf, B., Lecourt, S., Soulier, J., Ternaux, B., Lacassagne, M.-N., Crinquette, A., Dessoly, J., Sciaini, A.-K., Benbunan, M., Chomienne, C., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404466 · Cited by 190 · see citing works

Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression

Maiso, P., Mogollón, P., Ocio, E. M., & Garayoa, M. (2021) · Cancers · doi:10.3390/cancers13112542 · Cited by 48 · see citing works

Gene expression profiling, immunophenotypic and functional characterization of mesenchymal stem cells from bone marrow of multiple myeloma patients

Fernando, R. C. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)

The Analysis of the Relationship between Multiple Myeloma Cells and Their Microenvironment

Jurczyszyn, A. J., Zebzda, A., Czepiel, J., Gdula‐Argasińska, J., Perucki, W. H., Skotnicki, A. B., & Majka, M. (2015) · Journal of Cancer · doi:10.7150/jca.10873 · Cited by 15 · see citing works